サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1515450

PARP阻害剤バイオマーカー市場：製品別、サービス別、用途別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測

PARP Inhibitor Biomarkers Market, By Product, By Services, By Application, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 288 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.28円
PARP阻害剤バイオマーカー市場：製品別、サービス別、用途別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年06月04日
発行: AnalystView Market Insights
ページ情報: 英文 288 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

PARP阻害剤バイオマーカー市場規模は2023年に9億1,580万米ドルとなり、2024年から2032年にかけてCAGR 8.80%で拡大

PARP阻害剤バイオマーカー市場- 市場力学

がん管理・治療費用の増加が市場成長を促進

がんの管理・治療にかかる費用の増加が市場拡大を後押しすると予想されます。例えば、2022年10月にLancet Regional Health誌に掲載された論文では、インドで結腸直腸がんの全治療を希望する患者の治療中断と破局的費用について報告されています。対象となった226人の患者のうち、4人が追跡調査不能となり、20人が治療計画を受けてから6カ月以内に亡くなった。大腸がんの治療費は平均407,508インドルピー（INR/5340USD）でした。患者のPARP（中央値330,277INR/4328USD）がこの総費用の最大の貢献者でした。

PARP阻害剤バイオマーカー市場-主要インサイト

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024-2032年）に約8.80％のCAGRで毎年成長すると推定されます。

サービスセグメンテーションに基づくと、BRCA 1 &2検査カテゴリが2023年に最大市場シェアを示すと予測されました。

用途セグメンテーションに基づくと、2023年には乳がんカテゴリーが主要タイプでした。

地域別では、北米が2023年に収益でリードしました。

PARP阻害剤バイオマーカー市場-セグメンテーション分析：

世界のPARP阻害剤バイオマーカー市場は、製品、サービス、用途、地域に基づいて区分されます。

市場は製品によって2つのカテゴリーに分けられる：キットとアッセイです。キットは遺伝子の変異や変化に関連する疾患の検査や診断に使用されるため、キットカテゴリーが市場を独占しています。遺伝性DNA変異に関連する最も一般的な疾患の一つは乳がんです。正確で効率的な診断に対する需要の高まりに対応するため、市場の主要企業は継続的に新しいソリューションの開発に注力しています。相同組換え欠損症（HRD）陽性の進行卵巣がん患者を判定するためのFDA認可検査のひとつに、Myriad Genetics, Inc.のmyChoice CDxがあります。

市場は用途によって以下のカテゴリーに分けられる：乳がん、卵巣がん、その他。腫瘍カテゴリーが市場を独占しており、予測期間中もその優位性は維持されるとみられます。BRCA1またはBRCA2の遺伝子変異がもたらす遺伝子変化に関連した乳がんの頻度が増加していることが、このセグメントの拡大の理由と考えられています。2023年2月のWHOの記事によると、2040年までに250万人が乳がんに罹患すると予測されています。乳がんは女性に最も多いがんであり、世界の95％の国で女性ががんで死亡する主な原因となっています。にもかかわらず、生存率は大きく異なり、死亡の大部分は低・中所得国で起こっています。過去30年間、高所得国では乳がん死亡率が大幅に低下しているが、中低所得国ではそれに匹敵する低下は見られていないです。

PARP阻害剤バイオマーカー市場-地理的洞察

地理的に、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスを展開する国によってさらに分けられます。

予測期間中、北米がPARP阻害剤バイオマーカーの世界市場で最大のシェアを占めると予想されています。この高い比率は、がん治療費の上昇、ゲノム技術の進歩、がん罹患率の上昇に起因しています。米国がん協会（American Cancer Society）の論文によると、2022年には米国でがん関連死が約60万9,360人、新たにがんと診断される症例が190万人を超えると予測されています。その結果、がんがより一般的になるにつれて、PARP阻害剤治療の潜在的な候補者を特定するために遺伝子検査を利用する患者が増え、バイオマーカー検査のコストを押し上げています。

さらに、PARP阻害剤バイオマーカー市場は、Thermo Fisher Scientific, Inc.、QIAGEN、Illumina, Inc.などの地域および国内市場参入企業の存在により、アジア太平洋地域が予測期間中に世界で最も速い速度で拡大すると予想されています。同地域の成長には、ヘルスケアインフラを改善するための政府の取り組み、診断・治療製品の採用拡大につながる一人当たり所得の増加、同地域全体でPARP阻害剤バイオマーカー技術への投資が大幅に増加したことなども寄与すると予想されます。予測期間中、中国、日本、インドのような新興国は、新しい高度な機能を備えたスマートフォンの利用が増加しているため、市場拡大に拍車がかかると予想されます。

PARP阻害剤バイオマーカー市場-競合情勢：

この分野の主要企業としては、Ambry Genetics社、Myriad Genetics社、Thermo Fisher Scientific社、Illumina社が挙げられます。市場が高度に集中していることは、少数の生産者グループが市場シェアの大半を占めているという事実によって示されます。激しい競合に対抗するため、これらの企業はパートナーシップ、M&A、新製品の開発など、さまざまな戦略をとっています。

目次

第1章 PARP阻害剤バイオマーカー市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 PARP阻害剤バイオマーカーの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 PARP阻害剤バイオマーカー産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 PARP阻害剤バイオマーカー市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 PARP阻害剤バイオマーカー市場情勢

  • PARP阻害剤バイオマーカー市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 PARP阻害剤バイオマーカー市場- 製品別

  • 概要
    • セグメントシェア分析
    • キット
    • アッセイ

第8章 PARP阻害剤バイオマーカー市場- サービス別

  • 概要
    • セグメントシェア分析
    • BRCA 1および2検査
    • HRD検査
    • HRR検査
    • その他

第9章 PARP阻害剤バイオマーカー市場- 用途別

  • 概要
    • セグメントシェア分析
    • 乳がん
    • 卵巣がん
    • その他

第10章 PARP阻害剤バイオマーカー市場- 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- PARP阻害剤バイオマーカー業界

  • 競争ダッシュボード
  • 企業プロファイル
    • Myriad Genetics, Inc.
    • CENTOGENE NV
    • Thermo Fisher Scientific, Inc.
    • Illumina, Inc.
    • Agilent Technologies, Inc.
    • Amoy Diagnostics Co., Ltd.
    • Invitae Corporation
    • Ambry Genetics
    • NeoGenomics Laboratories.
    • QIAGEN.
    • Others

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE PARP Inhibitor Biomarkers Market: Product Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global PARP Inhibitor Biomarkers Market, by Product 2019-2032 (USD Million)
  • TABLE PARP Inhibitor Biomarkers Market: Services Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Services
  • TABLE Global PARP Inhibitor Biomarkers Market, by Services 2019-2032 (USD Million)
  • TABLE PARP Inhibitor Biomarkers Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global PARP Inhibitor Biomarkers Market, by Application 2019-2032 (USD Million)
  • TABLE PARP Inhibitor Biomarkers Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global PARP Inhibitor Biomarkers Market, by Region 2019-2032 (USD Million)
  • TABLE North America PARP Inhibitor Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE North America PARP Inhibitor Biomarkers Market, by Product, 2019-2032 (USD Million)
  • TABLE North America PARP Inhibitor Biomarkers Market, by Services, 2019-2032 (USD Million)
  • TABLE North America PARP Inhibitor Biomarkers Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe PARP Inhibitor Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe PARP Inhibitor Biomarkers Market, by Product, 2019-2032 (USD Million)
  • TABLE Europe PARP Inhibitor Biomarkers Market, by Services, 2019-2032 (USD Million)
  • TABLE Europe PARP Inhibitor Biomarkers Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific PARP Inhibitor Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific PARP Inhibitor Biomarkers Market, by Product, 2019-2032 (USD Million)
  • TABLE Asia Pacific PARP Inhibitor Biomarkers Market, by Services, 2019-2032 (USD Million)
  • TABLE Asia Pacific PARP Inhibitor Biomarkers Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America PARP Inhibitor Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America PARP Inhibitor Biomarkers Market, by Product, 2019-2032 (USD Million)
  • TABLE Latin America PARP Inhibitor Biomarkers Market, by Services, 2019-2032 (USD Million)
  • TABLE Latin America PARP Inhibitor Biomarkers Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa PARP Inhibitor Biomarkers Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa PARP Inhibitor Biomarkers Market, by Product, 2019-2032 (USD Million)
  • TABLE Middle East and Africa PARP Inhibitor Biomarkers Market, by Services, 2019-2032 (USD Million)
  • TABLE Middle East and Africa PARP Inhibitor Biomarkers Market, by Application, 2019-2032 (USD Million)

List of Figures

  • FIGURE PARP Inhibitor Biomarkers Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Product segment market share analysis, 2023 & 2032
  • FIGURE Product segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Services segment market share analysis, 2023 & 2032
  • FIGURE Services segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America PARP Inhibitor Biomarkers Market share and leading players, 2023
  • FIGURE Europe PARP Inhibitor Biomarkers Market share and leading players, 2023
  • FIGURE Asia Pacific PARP Inhibitor Biomarkers Market share and leading players, 2023
  • FIGURE Latin America PARP Inhibitor Biomarkers Market share and leading players, 2023
  • FIGURE Middle East and Africa PARP Inhibitor Biomarkers Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe PARP Inhibitor Biomarkers Market share analysis by country, 2023
  • FIGURE Germany PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific PARP Inhibitor Biomarkers Market share analysis by country, 2023
  • FIGURE India PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America PARP Inhibitor Biomarkers Market share analysis by country, 2023
  • FIGURE Brazil PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa PARP Inhibitor Biomarkers Market share analysis by country, 2023
  • FIGURE Saudi Arabia PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA PARP Inhibitor Biomarkers Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV3187

REPORT HIGHLIGHT

PARP Inhibitor Biomarkers Market size was valued at USD 915.8 Million in 2023, expanding at a CAGR of 8.80% from 2024 to 2032.

An agent that inhibits the cellular PARP enzyme. When DNA is broken, PARP aids in its repair. Numerous factors, including radiation, UV light exposure, some anticancer medications, and other compounds found in the environment, can harm DNA. In cancer treatment, PARP blocking may assist in preventing cancer cells from repairing their damaged DNA, which would ultimately lead to their demise. Known also as poly (ADP-ribose) polymerase inhibitors, PARP inhibitors are a class of targeted medicine.

PARP Inhibitor Biomarkers Market- Market Dynamics

Rising Costs for Cancer Management and Treatment to Propel Market Growth

Growing costs for the management and treatment of are anticipated to support market expansion. For instance, a journal paper from October 2022 in the Lancet Regional Health reported on treatment attrition and catastrophic costs for patients seeking full colorectal cancer therapy in India. Of the 226 patients that were included, four were lost to follow-up and 20 passed away within six months of receiving a treatment plan. Treatment for colorectal cancer cost, on average, 407,508 Indian Rupees (INR/5340 USD). The patient's PARP (median 330,277 INR/4328 USD) was the largest contributor to this total cost.

PARP Inhibitor Biomarkers Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.80 % over the forecast period (2024-2032)

Based on service segmentation, the BRCA 1 & 2 testing category was predicted to show maximum market share in the year 2023

Based on application segmentation, the breast cancer category was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

PARP Inhibitor Biomarkers Market- Segmentation Analysis:

The Global PARP Inhibitor Biomarkers Market is segmented on the basis of Product, Service, Application, and Region.

The market is divided into two categories based on product: Kits and Assays. The kits category dominates the market because these kits are used to test for and diagnose diseases associated with mutations and changes in genes. One of the most prevalent diseases linked to inherited DNA mutations is breast cancer. In order to address the growing demand for accurate and efficient diagnostics, major players in the market are continuously concentrating on developing new solutions. One FDA-approved test for determining individuals with advanced ovarian cancer who have a positive homologous recombination deficiency (HRD) status is myChoice CDx from Myriad Genetics, Inc.

The market is divided into the following categories based on application: Breast Cancer, Ovarian Cancer, and Others. The oncology category dominates the market and is likely to maintain its dominance during the forecast period. The increasing frequency of breast cancer linked to gene alterations brought on by BRCA1 or BRCA2 genetic mutations is thought to be the reason for the segment's expansion. The WHO article from February 2023 states that It is predicted that 2.5 million people would be affected by breast cancer by 2040. Breast cancer is the most common type of cancer in women and the main cause of cancer-related deaths in women in 95% of the world's countries. In spite of this, survival rates differ greatly, and the bulk of deaths take place in low- and middle-income nations. Over the past three decades, breast cancer mortality rates have significantly decreased in high-income countries, whereas low- and middle-income countries have not seen a comparable decline.

PARP Inhibitor Biomarkers Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Over the course of the forecast period, North America is anticipated to hold the greatest share of the global market for PARP inhibitor biomarkers. This high percentage can be attributed to rising cancer treatment costs, advances in genomic technologies, and rising cancer prevalence. An article from the American Cancer Society projects that in 2022, there will be about 609,360 cancer-related deaths and over 1.9 million new cancer cases diagnosed in the United States. As a result, as cancer is becoming more common, more patients are using genetic testing to identify potential candidates for PARP inhibitor therapy, which is driving up the cost of biomarker testing.

In addition, the PARP inhibitor biomarkers market is anticipated to expand at the fastest rate in the world during the projected period in Asia Pacific ascribed to the existence of significant regional and national market participants including Thermo Fisher Scientific, Inc., QIAGEN, and Illumina, Inc. The region's growth is also expected to be fueled by government initiatives to improve healthcare infrastructure, a rise in per capita income that leads to a greater adoption of diagnostic and therapy products, and significantly increased investments in PARP inhibitor biomarkers technologies throughout the region. Over the course of the forecast period, emerging nations like China, Japan, and India are expected to fuel the market expansion due to the growing usage of smartphones with new advanced features.

PARP Inhibitor Biomarkers Market- Competitive Landscape:

Among the leading businesses in the field are Ambry Genetics, Myriad Genetics, Inc., Thermo Fisher Scientific, Inc., and Illumina, Inc. A highly concentrated market is indicated by the fact that a small group of producers have the majority of the market share. To counter the intense competition, these companies have turned to a variety of strategies, including partnerships, mergers and acquisitions, and the creation of new products.

Recent Developments:

February 2024: The genetic testing and precision medicine startup Myriad Genetics, Inc. has successfully acquired a number of assets from Intermountain Health's Intermountain Precision Genomics (IPG) laboratory group. The purchase includes his CLIA-certified laboratory in St. George, Utah, as well as Precision Fluid Testing and Precision Oncology Testing.

January 2024: ASCO and SSO guidelines about germline testing for breast cancer patients are something that Myriad Genetics, Inc., a manufacturer of genetic testing and precision medicine, has stated its support for. The business highlights the updating of the ASCO-SSO guidelines as a major step forward in the integration of genetics into patient treatment.

January 2023: Finding novel indicators for prostate cancer resistance to PARP medicines is made possible in large part by CRISPR technology. Researchers have used genome-wide CRISPR knockout screens to investigate the ways in which distinct genetic alterations affect PARP drug effectiveness. The identification of MMS22L, a gene that, when deleted, dramatically improves the sensitivity to PARP inhibitors, is a noteworthy finding from these investigations.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PARP INHIBITOR BIOMARKERS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Myriad Genetics, Inc.

CENTOGENE N.V.

Thermo Fisher Scientific, Inc.

Illumina, Inc.

Agilent Technologies, Inc.

Amoy Diagnostics Co., Ltd.

Invitae Corporation

Ambry Genetics

NeoGenomics Laboratories.

QIAGEN

Others

GLOBAL PARP INHIBITOR BIOMARKERS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Kits
  • Assays

GLOBAL PARP INHIBITOR BIOMARKERS MARKET, BY SERVICE- MARKET ANALYSIS, 2019 - 2032

  • BRCA 1 & 2 Testing
  • HRD Testing
  • HRR Testing
  • Others

GLOBAL PARP INHIBITOR BIOMARKERS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Breast Cancer
  • Ovarian Cancer
  • Others

GLOBAL PARP INHIBITOR BIOMARKERS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. PARP Inhibitor Biomarkers Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. PARP Inhibitor Biomarkers Market Snippet by Product
    • 2.1.2. PARP Inhibitor Biomarkers Market Snippet by Services
    • 2.1.3. PARP Inhibitor Biomarkers Market Snippet by Application
    • 2.1.4. PARP Inhibitor Biomarkers Market Snippet by Country
    • 2.1.5. PARP Inhibitor Biomarkers Market Snippet by Region
  • 2.2. Competitive Insights

3. PARP Inhibitor Biomarkers Key Market Trends

  • 3.1. PARP Inhibitor Biomarkers Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. PARP Inhibitor Biomarkers Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. PARP Inhibitor Biomarkers Market Opportunities
  • 3.4. PARP Inhibitor Biomarkers Market Future Trends

4. PARP Inhibitor Biomarkers Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. PARP Inhibitor Biomarkers Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. PARP Inhibitor Biomarkers Market Landscape

  • 6.1. PARP Inhibitor Biomarkers Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. PARP Inhibitor Biomarkers Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 7.1.2. Kits
    • 7.1.3. Assays

8. PARP Inhibitor Biomarkers Market - By Services

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Services, 2023 & 2032 (%)
    • 8.1.2. BRCA 1 & 2 Testing
    • 8.1.3. HRD Testing
    • 8.1.4. HRR Testing
    • 8.1.5. Others

9. PARP Inhibitor Biomarkers Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Breast Cancer
    • 9.1.3. Ovarian Cancer
    • 9.1.4. Others

10. PARP Inhibitor Biomarkers Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. PARP Inhibitor Biomarkers Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. PARP Inhibitor Biomarkers Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. PARP Inhibitor Biomarkers Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. PARP Inhibitor Biomarkers Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. PARP Inhibitor Biomarkers Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Services, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- PARP Inhibitor Biomarkers Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Myriad Genetics, Inc.
    • 11.2.2. CENTOGENE N.V.
    • 11.2.3. Thermo Fisher Scientific, Inc.
    • 11.2.4. Illumina, Inc.
    • 11.2.5. Agilent Technologies, Inc.
    • 11.2.6. Amoy Diagnostics Co., Ltd.
    • 11.2.7. Invitae Corporation
    • 11.2.8. Ambry Genetics
    • 11.2.9. NeoGenomics Laboratories.
    • 11.2.10. QIAGEN.
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us